Novel kinase inhibitor drugs to treat respiratory disease or breast cancer
— Disease indications:
Drug format: small molecule
Drug class: first in class
Research stage and Preliminary data:
Preclinical development of the lead compound for respiratory disease includes in vitro and in vivo efficacy, selectivity and initial toxicity testing. Preclinical development of the…